Rosetta Licenses Greek miRNA Dx Rights to Genekor

The deal covers Rosetta's miRview Meso, miRview Mets, and miRview Squamous tests.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.